We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Assessment of the Skin-concentration of Vildagliptin 50 mg Every 12 Hours for 10 Days in Healthy Subjects and Patients With Type 2 Diabetes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00633997
Recruitment Status : Terminated (After analysis of the existing data, it was determined that additional skin biopsy samples would not be required to determine study outcome.)
First Posted : March 12, 2008
Last Update Posted : May 24, 2016
Information provided by (Responsible Party):

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : December 2008
  Study Completion Date : No date given
  Certification or Request for Extension to Delay Results Submission: April 25, 2016